Compounds > 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and lead radioisotopes

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with lead radioisotopes in 1 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Studies
(lead radioisotopes)		Trials
(lead radioisotopes)		Recent Studies (post-2010) (lead radioisotopes)
25487805375

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruland, OS; Hassfjell, SP; Hoff, P1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and lead radioisotopes

ArticleYear
212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy.
    Nuclear medicine and biology, 1997, Volume: 24, Issue:3

    Topics: Alpha Particles; Animals; Bismuth; Bone and Bones; Drug Stability; Female; Femur; Lead Radioisotopes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Radioisotopes; Radiopharmaceuticals; Tissue Distribution

1997